Showing results (211-220 of 415) with videos related to

Sort By:
Pageof 42
Journal of Reproduction and Fertility. Supplement|January 1, 1989
Efficacy of oral epostane administration to terminate pregnancy in mated laboratory bitchesD M Keister, R F Gutheil, L D Kaiser, et al.
Klinische Padiatrie|March 1, 1988
CA 19-9, CA 50 and elastase 1 as additional markers of cystic fibrosisG Uhlenbruck, U Scheuring, C Dienst, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Pattern formation and traveling waves in myxobacteria: theory and modelingO A Igoshin, A Mogilner, R D Welch, et al.
Frontiers in Behavioral Neuroscience|February 20, 2014
Development of brain mechanisms for processing affective touchMalin Björnsdotter, Ilanit Gordon, Kevin A Pelphrey, et al.
The European Respiratory Journal|April 1, 1992
Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokersT Schaberg, H Haller, M Rau, et al.
Journal of Clinical Medicine|November 27, 2024
Impaired Kidney Function and 10-Year Outcome After Percutaneous Coronary Intervention-Interaction with Age, Sex, Diabetic Status and Clinical PresentationGjin Ndrepepa, Sebastian Kufner, Salvatore Cassese, et al.
European Journal of Clinical Investigation|January 24, 2024
Aspirin loading and coronary no-reflow after percutaneous coronary intervention in patients with acute myocardial infarctionGjin Ndrepepa, Salvatore Cassese, Erion Xhepa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 16, 2024
Left ventricular systolic function after percutaneous coronary intervention: patterns of change and prognosis according to clinical presentation of coronary artery diseaseGjin Ndrepepa, Salvatore Cassese, Michael Joner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 14, 2023
Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitorsGjin Ndrepepa, Salvatore Cassese, Erion Xhepa, et al.
Pageof 42